Euracare Defends Doctors Suspended Over Death Of Chimamanda Adichie’s Son

Euracare Multispecialist Hospital has defended two of its doctors who were temporarily suspended by the Medical and Dental Council of Nigeria (MDCN) after the death of Chimamanda Adichie’s son.

The hospital raised concerns about the investigation process and said there had been a “serious breach” of confidentiality.

The suspension came after the MDCN panel began looking into the death of Nkanu Adichie-Esege, one of Chimamanda Adichie’s twins, who passed away on January 7, 2026, following complications during routine medical procedures.

Chimamanda had sent a legal notice to Euracare, claiming that her son’s death was caused by medical negligence and professional misconduct.

The MDCN then set up a panel to investigate these claims.

The panel concluded that there was a prima facie case of medical negligence against Euracare and Atlantis Hospital in handling Nkanu’s care.

As a result, Tunde Majekodunmi, Euracare’s medical director; Titus Ogundare, the anaesthesiologist; and Atinuke Uwajeg, chief medical officer at Atlantis, were suspended.

The doctors are not allowed to practise medicine in Nigeria until the disciplinary tribunal decides on their cases.

Enejo Abdu, the panel’s secretary, also said the investigation found enough evidence of professional misconduct against ten other doctors at Atlantis Hospital.

The panel finished its investigation during its 25th session in Abuja on February 17 and 18.

In a statement on Wednesday, Euracare said it remains ready to cooperate fully with all regulatory and judicial authorities.

The hospital, however, defended the two suspended doctors, calling them experienced professionals who have contributed significantly to healthcare in Nigeria.

“Both doctors have, in their respective careers, contributed meaningfully to the delivery of quality healthcare to Nigerian patients at a standard comparable to what is obtainable in the world’s leading medical facilities,” the statement reads.

Euracare added that it had conducted a full internal review of the events, following its governance and best practice standards.

It emphasized its commitment to transparency and said it would continue to engage openly with the investigations.

The hospital, however, expressed concern about how the process had been handled.

“It is our position that certain established processes and protocols have not been followed in the manner required,” it said.

“We have further noted, with deep concern, that matters covered by patient and institutional confidentiality appear to have been disclosed outside the appropriate channels, and we consider this a serious breach that cannot go unaddressed.”

The hospital stressed that all parties, including staff and the institution itself, are entitled to a fair and impartial process.

It said it would raise these concerns through the appropriate legal and regulatory channels.

While defending its doctors, Euracare also expressed sympathy for the family, noting that losing a child brings “a grief without measure” and that the hospital keeps this in mind in all statements and actions regarding the case.

Meanwhile, a coroner at the Yaba Magistrate Court in Lagos has fixed April 14, 2026, to begin proceedings into the death of Chimamanda’s son, Nkanu Nnamdi.